A phase I trial of sequential administration of Triapine (3-aminopyridine-2-carboxaldehyde) [OCX 0191] followed by fludarabine in adults with relapsed and refractory leukemias and myelodysplasias.
Phase of Trial: Phase I
Latest Information Update: 23 May 2018
At a glance
- Drugs OCX 191 (Primary) ; Fludarabine
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Adverse reactions
- 09 Sep 2005 New trial record.